The Inhibitory Receptor PD-1 Regulates IgA Selection and Bacterial Composition in the Gut
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Gut Reaction: The gut needs to keep its trillions of microbial inhabitants contained. The immune system has evolved a multifaceted approach to this problem, which includes the production of large quantities of immunoglobulin A (IgA) in the intestinal mucosa. In a process that is not well understood, plasma cells that produce IgA specific for the gut microflora are selected in Peyer's patches in the gut. Kawamoto et al. (p. 485) used genetically manipulated mice to show that the inhibitory co-receptor, programmed cell death-1 (PD-1), is required for the proper selection IgA-secreting cells in the gut. The effect of PD-1 deletion, however, was not intrinsic to the B cells that produce IgA. Instead, the absence of PD-1 affected the differentiation of T follicular helper cells, which provide important signals to B cells that help guide them as they develop the capacity to produce microflora-specific IgA. Mice deficient in PD-1 exhibited alterations in the composition in their microflora, which suggests that defective selection of IgA can perturb the careful balance that exists between the immune system and resident bacteria.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In turn, defective IgA secretion or function induces microbial dysbiosis [46, 47].”
From Gut microbiota-mediated immunomodulation in tumor (2021) · cites this paper as [46]
In the citing paper
“Tfh cells are implicated in maintenance of microbiota homeostasis as highlighted by studies showing that impairment of Tfh cells resulting from lack of expression of co-receptor programmed cell death 1 (PD-1) or ATP-gated ionotropic P2RX7 receptor can alter gut microbiota composition.117,118”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [117]
Citations
Cites
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., & Honjo, T. (2000) · Cell · doi:10.1016/s0092-8674(00)00078-7 · Cited by 3,474
Self-citationNishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749
Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle Progression
Sakaue-Sawano, A., Kurokawa, H., Morimura, T., Hanyu, A., Hama, H., Osawa, H., Kashiwagi, S., Fukami, K., Miyata, T., Miyoshi, H., et al. (2008) · Cell · doi:10.1016/j.cell.2007.12.033 · Cited by 2,173
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
Victora, G. D., Schwickert, T. A., Fooksman, D. R., Kamphorst, A. O., Meyer-Hermann, M., Dustin, M. L., & Nussenzweig, M. C. (2010) · Cell · doi:10.1016/j.cell.2010.10.032 · Cited by 1,238
IMGT(R), the international ImMunoGeneTics information system(R)
Lefranc, M.-P., Giudicelli, V., Ginestoux, C., Jabado-Michaloud, J., Folch, G., Bellahcene, F., Wu, Y., Gemrot, E., Brochet, X., Lane, J., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn838 · Cited by 1,119
A Primitive T Cell-Independent Mechanism of Intestinal Mucosal IgA Responses to Commensal Bacteria
Macpherson, A. J., Gatto, D., Sainsbury, E., Harriman, G. R., Hengartner, H., & Zinkernagel, R. M. (2000) · Science · doi:10.1126/science.288.5474.2222 · Cited by 1,113
Intraclonal generation of antibody mutants in germinal centres
Jacob, J., Kelsoe, G., Rajewsky, K., & Weiss, U. (1991) · Nature · doi:10.1038/354389a0 · Cited by 1,090
Imaging of Germinal Center Selection Events During Affinity Maturation
Allen, C. D. C., Okada, T., Tang, H. L., & Cyster, J. G. (2007) · Science · doi:10.1126/science.1136736 · Cited by 779
Cited by
Items 201–300 of 482
Okagawa, T., Konnai, S., Nishimori, A., Ikebuchi, R., Mizorogi, S., Nagata, R., Kawaji, S., Tanaka, S., Kagawa, Y., Murata, S., et al. (2015) · Infection and Immunity · doi:10.1128/iai.01014-15 · Cited by 47
“To con- Exhaustion of M. paratuberculosis-Specific T Cells January 2016 Volume 84 Number 1 iai.asm.org 81Infection and Immunity firm the potential of macrophages from infected cattle to interact with T cells through immunoinhibitory ligands, the expression status of PD-L1 and MHC-II on macrophages from blood, spleens,…”
BackgroundInfluentialXu, H., Wang, X., Lackner, A. A., & Veazey, R. S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00085 · Cited by 46
“Although PD-1 expression is associated with inhibition of T-cell responses in chronic viral infections (7, 17), high PD-1 expression on TFH cells is also critical for regulating GC formation, B cell survival, affinity maturation of plasma cells, and IgA secretion in the gut (9, 18).”
BackgroundXu, H., Wang, X., Malam, N., Lackner, A. A., & Veazey, R. S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501273 · Cited by 46
“indicates high expression of PD-1 on CXCR5PD-1 Tfh cells is critical for regulating GC formation and promoting B cell maturation and Ab production (7, 26).”
BackgroundLi, Y., Ye, Z., Zhu, J., Fang, S., Meng, L., & Zhou, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.844335 · Cited by 45
Exploring the role of gut microbiome in autoimmune diseases: A comprehensive review
Wang, H., Cai, Y., Wu, W. ‐., Zhang, M., Dai, Y., & Wang, Q. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103654 · Cited by 45
Regulatory T cells and control of the germinal centre response
Vanderleyden, I., Linterman, M. A., & Smith, K. G. C. (2014) · Arthritis Research & Therapy · doi:10.1186/s13075-014-0471-7 · Cited by 45
“PD-1 ligation on Tfh cells during interaction with B cells controls the Tfh cell number, and secretion of the cytokine IL-21 and CD80 expression on B cells supports Tfh survival [32,33].”
BackgroundThe Role of the Gut Microbiota in the Pathogenesis of Antiphospholipid Syndrome
Ruff, W. E., Vieira, S. M., & Kriegel, M. A. (2014) · Current Rheumatology Reports · doi:10.1007/s11926-014-0472-1 · Cited by 45
Molecular Control of Follicular Helper T cell Development and Differentiation
Wu, H., Deng, Y., Zhao, M., Zhang, J., Zheng, M., Chen, G., Li, L., He, Z., & Lu, Q. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02470 · Cited by 43
“PD-1 has been found to limit the number of Tfh cells (21).”
BackgroundPD-1 Suppresses Protective Immunity to Streptococcus pneumoniae through a B Cell–Intrinsic Mechanism
McKay, J. T., Egan, R., Yammani, R. D., Chen, L., Shin, T., Yagita∥, H., & Haas, K. M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401673 · Cited by 43
“Other studies have shown PD-1–mediated effects on B cell responses in vivo (21, 26, 33, 34).”
BackgroundCampredon, P., Mouly, C., Lusque, A., Bigay-Game, L., Bousquet, E., Mazières, J., & Caron, P. J. (2019) · La Presse Médicale · doi:10.1016/j.lpm.2018.10.019 · Cited by 43
Zeng, W., Qin, S., Wang, R., Zhang, Y., Ma, X., Tian, F., Liu, X., Qin, X., Liao, S., Sun, L., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2313-7 · Cited by 42
Cao, Y., Yang, Q., Deng, H., Tang, J., Hu, J., Liu, H., Zhi, M., Ye, L., Zou, B., Liu, Y., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818164116 · Cited by 43
“In contrast to intensive studies on systemic TFH cells, the mechanism regulating gut TFH cells remains poorly understood (6, 10).”
ResultMcKay, J. T., Haro, M., Daly, C. A., Yammani, R. D., Pang, B., Swords, W. E., & Haas, K. M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700555 · Cited by 41
“We therefore sought to determine if the microbiota influenced the natural PC-specific Ab levels in PD-L2 mice using broad-spectrum antibiotic (ABX) therapy as previously described (57).”
BackgroundMethodMicrobiota — an amplifier of autoimmunity
Vogelzang, A., Guerrini, M. M., Minato, N., & Fagarasan, S. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.09.003 · Cited by 41
Self-citationWang, M., Doenyas, C., Wan, J., Zeng, S., Cai, C., Zhou, J., Liu, Y., Yin, Z., & Zhou, W. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.12.012 · Cited by 41
“Therefore, gut IgA is instrumental in controlling the composition of commensal microbiota [10].”
BackgroundLiu, X., Yu, R., & Zou, K. (2019) · Current Medical Science · doi:10.1007/s11596-019-2045-z · Cited by 40
Reciprocal regulation of IgA and the gut microbiota: a key mutualism in the intestine
Takeuchi, T., & Ohno, H. (2021) · International Immunology · doi:10.1093/intimm/dxab049 · Cited by 40
Shirakashi, M., Maruya, M., Hirota, K., Tsuruyama, T., Matsuo, T., Watanabe, R., Murata, K., Tanaka, M., Ito, H., Yoshifuji, H., et al. (2021) · Arthritis & Rheumatology · doi:10.1002/art.42016 · Cited by 40
“For example, Aicda-knockout mice were shown to develop gut dysbiosis with the expansion of SFB (37), Ltbr-knockout mice failed to form Peyer’s patches, which resulted in SFB expansion and induced the production of ANAs (38), and Pdcd1 deficiency resulted in the expansion of functionally impaired Tfh in Peyer’s patches…”
BackgroundMethodSelf-citationNiu, W., Yang, F., Fu, Z., Dong, Y., Zhang, Z., & Ju, J. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.105381 · Cited by 40
Isotype-specific plasma cells express divergent transcriptional programs
Higgins, B. W., Shuparski, A. G., Miller, K. B., Robinson, A. M., McHeyzer‐Williams, L. J., & McHeyzer‐Williams, M. G. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121260119 · Cited by 40
Carreto-Binaghi, L. E., Sztein, M. B., & Booth, J. S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1446072 · Cited by 41
“In addition, PD-1 knock out mice (PD-1 -/- ) are unable to promote a fully functional IgA response; however, they have relatively unaffected GC in the PP (116).”
BackgroundFollicular T‐helper cells: controlled localization and cellular interactions
Qi, H., Chen, X., Chu, C., Lu, P., Xu, H., & Yan, J. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2013.59 · Cited by 39
Microbial Stimulation Reverses the Age-Related Decline in M Cells in Aged Mice
Donaldson, D. S., Pollock, J., Vohra, P., Stevens, M. P., & Mabbott, N. A. (2020) · iScience · doi:10.1016/j.isci.2020.101147 · Cited by 39
“Interestingly, this drives PD-L1 expression in the Peyer’s patch, which may signal to Tfh cells through PD-1, an absence of which alters the GC response and results in poor IgA selection (Kawamoto et al., 2012).”
BackgroundInteraction between IgA and gut microbiota and its role in controlling metabolic syndrome
Guo, J., Han, X., Huang, W., You, Y., & Zhan, J. (2020) · Obesity Reviews · doi:10.1111/obr.13155 · Cited by 39
“However, the proportion of IgA-coated bacteria was reduced in these mice, while Enterobacteriaceae, belonging to Proteobacteria, was significantly increased.(94) These results suggest that although IgA from WT and T cell-dysfunctional mice can bind to similar bacterial taxa, the outcomes of these bindings can be discr…”
BackgroundResultZhao, H., Wang, H., Zhou, Q., & Ren, X. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2021.0029 · Cited by 39
Reciprocal interactions between gut microbiota and autophagy
Lapaquette, P., Bizeau, J.-B., Acar, N., & Bringer, M.-A. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i48.8283 · Cited by 39
Ukibe, K., Miyoshi, M., & Kadooka, Y. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515002627 · Cited by 39
“Given that the secreted IgA antibody has the potential to modify the composition of microbiota((41)), the administration of LG2055 could affect the state of inflammation through the compositional alteration.”
BackgroundLin, Y.-L., Ip, P.-P., & Liao, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00805 · Cited by 39
Correlation between gut microbiota dysbiosis, metabolic syndrome and breast cancer
Abdelqader, E. M., Mahmoud, W. S., Gebreel, H. M., Kamel, M. M., & Abu‐Elghait, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-89801-8 · Cited by 38
“The study’s findings of increased breast cancer risk in women with MetS are consistent with previous research 39,40 .”
Uncoupling Therapeutic Efficacy from Immune-Related Adverse Events in Immune Checkpoint Blockade
Hu, W., Wang, G., Wang, Y., Riese, M. J., & You, M. (2020) · iScience · doi:10.1016/j.isci.2020.101580 · Cited by 38
Ogishi, M., Kitaoka, K., Good‐Jacobson, K. L., Rinchai, D., Zhang, B., Wang, J., Gies, V., Rao, G., Nguyen, T., Avery, D. T., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.10.014 · Cited by 37
Akrami, M., Menzies, R. J., Chamoto, K., Miyajima, M., Suzuki, R., Sato, H., Nishii, A., Tomura, M., Fagarasan, S., & Honjo, T. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010981117 · Cited by 38
Self-citationFine-tuning of the mucosal barrier and metabolic systems using the diet-microbial metabolite axis
Nagai, M., Obata, Y., Takahashi, D., & Hase, K. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.04.001 · Cited by 37
THE ROLE OF INTESTINAL MICROBIOTA IN CHICKEN HEALTH, INTESTINAL PHYSIOLOGY AND IMMUNITY
Qamar, A., Waheed, J., Hamza, A. A., Mohyuddin, S. G., Lu, Z., Namula, Z., Chen, Z., & Chen, J. (2020) · The Journal of Animal and Plant Sciences · doi:10.36899/japs.2021.2.0221 · Cited by 36
“There seems to be a correlation in animal performance and a “healthy” gut of animal Liu et al. (2019). The basic purpose of the healthy gut is to modify physical homeostasis that delivers the host capability to resist pathogenic stimuli Guo et al.”
BackgroundRegulation of the gut microbiota by the mucosal immune system in mice
Hasegawa, M., & Inohara, N. (2014) · International Immunology · doi:10.1093/intimm/dxu049 · Cited by 37
Zhang, X., Liu, Z., Zhang, H., Li, Y., Wen, S., Shen, J., Huang, W., & Liu, K. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12789 · Cited by 36
“Flow cytometric analysis of IgA-binding bacteria was performed as previously described [19].”
MethodWatanabe, Y., Arase, S., Nagaoka, N., Kawai, M., & Matsumoto, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150559 · Cited by 35
Li, Y., Huan, Y., Qin, W., Yu, X., Chang, Y., Xue, C., & Tang, Q. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.132093 · Cited by 35
Bacterial and host fucosylation maintain IgA homeostasis to limit intestinal inflammation in mice
Lei, C., Luo, C., Xu, Z., Ding, S., Sriwastva, M. K., Dryden, G. W., Wang, T., Xu, M., Tan, Y. H., Wang, Q., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01873-w · Cited by 35
Activation of B cells by non‐canonical helper signals
Cerutti, A., Cols, M., & Puga, I. (2012) · EMBO Reports · doi:10.1038/embor.2012.111 · Cited by 37
High-affinity IgA needs TH17 cell functional plasticity
Milpied, P., & McHeyzer‐Williams, M. G. (2013) · Nature Immunology · doi:10.1038/ni.2567 · Cited by 35
Do Long-Lived Plasma Cells Maintain a Healthy Microbiota in the Gut?
Jahnsen, F. L., Bækkevold, E. S., Hov, J. R., & Landsverk, O. J. B. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.10.006 · Cited by 35
Gut Microbiota–Host Interactions in Inborn Errors of Immunity
Castagnoli, R., Pala, F., Bosticardo, M., Licari, A., Delmonte, O. M., Villa, A., Marseglia, G. L., & Notarangelo, L. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031416 · Cited by 34
“The absence of the co-receptor PD-1 on these cells can alter the microbiota composition [55].”
BackgroundWilliams, L. M., & Cao, S. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108605 · Cited by 35
Peng, C., Hu, Q., Yang, F., Zhang, H., Li, F., & Huang, C. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800876 · Cited by 34
“However, although some studies have found that humoral responses are suppressed (12, 13), others have reported that”
BackgroundThe PD-1/PD-L1 Checkpoint in Normal Germinal Centers and Diffuse Large B-Cell Lymphomas
Garcia-Lacarte, M., Grijalba, S. C., Melchor, J., Arnaiz-Leché, A., & Roa, S. (2021) · Cancers · doi:10.3390/cancers13184683 · Cited by 34
“These apparently contradictory TFH phenotypes might be capturing differences in PD-1 signaling by PD-L1 or PD-L2, but ultimately reinforce the idea that despite the negative role of PD-1 in TFH development, PD-1 is required for optimal IL-21 production by TFH cells and tight regulation of GC B cell survival [24,27,30]…”
BackgroundPhetsouphanh, C., Xu, Y., & Zaunders, J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00681 · Cited by 35
Function and dysfunction of plasma cells in intestine
Wang, X., Hao, G., Wang, B., Gao, C., Wang, Y.-X., Li, L.-S., & Xu, J. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0288-9 · Cited by 33
Bcl-6 controlled TFH polarization and memory: the known unknowns
Qi, H., Liu, D., Ma, W., Wang, Y., & Yan, H. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.01.016 · Cited by 33
“PD-1 is involved in regulating plasma cell differentiation [43,44], but cellular mechanisms remain to be clarified.”
CX3CR1+ Macrophages and CD8+ T Cells Control Intestinal IgA Production
Kim, Y.-I., Song, J.-H., Ko, H., Kweon, M., Kang, C., Reinecker, H., & Chang, S.-Y. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701459 · Cited by 33
“T cells could contribute to the regulation of IgA similar to the function of PD-1 on CD4 Tregs (50).”
BackgroundType 1 diabetes pathogenesis and the role of inhibitory receptors in islet tolerance
Martinov, T., & Fife, B. T. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14106 · Cited by 32
Autoimmunity in microbiome-mediated diseases and novel therapeutic approaches
Shin, C., & Kim, Y. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.04.018 · Cited by 30
The Mycobiome: Impact on Health and Disease States
El‐Jurdi, N., & Ghannoum, M. A. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.funk-0045-2016 · Cited by 30
Vaquero, S. T., Neuman, H., Comerma, L., Marcos-Fa, X., Corral-Vázquez, C., Uzzan, M., Pybus, M., Segura-Garzón, D., Guerra, J., Perruzza, L., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20230079 · Cited by 29
“…CSR can occur inside or outside mucosal GCs (Bunker et al., 2015; He et al., 2007; Reboldi et al., 2016; Roco et al., 2019; Wang et al., 2017), SHM mostly occurs in mucosal GCs in response to TD signals (Chen et al., 2020; Kawamoto et al., 2012, 2014; Nowosad et al., 2020; Seikrit and Pabst, 2021).”
Sugisaka, J., Toi, Y., Taguri, M., Kawashima, Y., Aiba, T., Kawana, S., Saito, R., Aso, M., Tsurumi, K., Suzuki, K., et al. (2019) · JMA Journal · doi:10.31662/jmaj.2019-0005 · Cited by 29
“One study reported high PD-1 expression in activated B cells ((25)), and this may be modulated by T-cell-dependent and T-cell-independent mechanisms (26), (27), ((28)).”
BackgroundSelf-citationOu, X., Xu, S., Li, Y.-F., & Lam, K. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400539111 · Cited by 29
“Blocking PD-1 signaling by deleting either PD-1 or PD-1 ligands resulted in the expansion of Tfh cells with altered cytokine production and impaired antibody production and IgA diversification (6, 8).”
BackgroundGu, X., Sun, R., Chen, L., Chu, S., Doll, M. A., Li, X., Feng, W., Siskind, L. J., McClain, C. J., & Deng, Z. (2021) · Hepatology · doi:10.1002/hep.31628 · Cited by 28
Gupta, V. K., Janda, G., Pump, H. K., Lele, N., Cruz, I., Cohen, I., Ruff, W. E., Hafler, D. A., Sung, J., & Longbrake, E. E. (2025) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200355 · Cited by 27
Harnessing mucosal immunity for protective vaccines
Kwon, D.-I., Bhagchandani, S. H., Ehrenzeller, S. A., & Iwasaki, A. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01273-7 · Cited by 27
The gut microbiota and its products: Establishing causal relationships with obesity related outcomes
Li, L., Zhang, Y., Speakman, J. R., Hu, S., Song, Y., & Qin, S. (2021) · Obesity Reviews · doi:10.1111/obr.13341 · Cited by 27
Greisen, S. R., Aspari, M., & Deleuran, B. W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.883733 · Cited by 27
“Considering the evolving evidence of the major significance of the microbiota in the development of autoimmune diseases, including both rheumatic and gastrointestinal diseases, the role of CTLA-4, in combination with PD-1 is further highlighted by both their abilities to influence IgA synthesis and the microbiome (78,…”
BackgroundZogorean, R., & Wirtz, S. J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1260266 · Cited by 27
“When Tfr are absent, T follicular helper cells increase and affect the response of GC reaction towards more poly or self-reactive B cells (141, 142) (Figure 1).”
Aging Gut Microbiome in Healthy and Unhealthy Aging
Yangyanqiu, W., Qu, Z., Chu, J., & Han, S. (2024) · Aging and Disease · doi:10.14336/ad.2024.0331 · Cited by 27
Koulouridi, A., Messaritakis, I., Gouvas, N., Tsiaoussis, J., & Souglakos, J. (2020) · Cancers · doi:10.3390/cancers13010043 · Cited by 27
“PD-1deficient mice produce IgAs not capable to properly bind bacteria, and bacterial diversity is disturbed in companion with antibodies required to maintain a mucosal barrier, thus leading to dysbiosis [54].”
BackgroundTipping the balance: inhibitory checkpoints in intestinal homeostasis
Joosse, M. E., Nederlof, I., Walker, L. S. K., & Samsom, J. N. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0113-5 · Cited by 26
Shi, W., Yang, B. Y., Sun, Q., Meng, J., Zhao, X. Q., Du, S., Li, X., & Jiao, S. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106295 · Cited by 26
Zhang, F., Yang, J., Zhan, Q., Shi, H., Li, Y., Li, D., Li, Y., & Yang, X. (2023) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-023-00857-w · Cited by 26
“SIgA was dysregulated and led to the change of microbial communities [29].”
BackgroundT Follicular Regulatory Cells and Antibody Responses in Transplantation
Wallin, E. F. (2018) · Transplantation · doi:10.1097/tp.0000000000002224 · Cited by 25
Renand, A., Milpied, P., Rossignol, J., Bruneau, J., Lemonnier, F., Dussiot, M., Coulon, S., & Hermine, O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0085589 · Cited by 25
“The costimulatory molecules ICOS, PD-1, CD40 ligand, and SAP (signaling lymphocytic activation molecule associated protein) play a major role in facilitating the differentiation of B cells [7-10].”
BackgroundImmune regulation of sickle cell alloimmunization
Yazdanbakhsh, K., Shaz, B. H., & Hillyer, C. D. (2016) · ISBT Science Series · doi:10.1111/voxs.12296 · Cited by 24
Cosorich, I., McGuire, H. M., Warren, J. A., Danta, M., & King, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02899 · Cited by 24
Programmed Death-1 Restrains the Germinal Center in Type 1 Diabetes
Martinov, T., Swanson, L. A., Breed, E. R., Tucker, C., Dwyer, A. J., Johnson, J. K., Mitchell, J. S., Sahli, N. L., Wilson, J. C., Singh, L. M., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801535 · Cited by 24
“leading to greater IAA production but lower overall IAA affinity (11, 44, 46).”
BackgroundPD ‐1 modulates steady‐state and infection‐induced IL ‐10 production in vivo
McBerry, C., Dias, A., Shryock, N., Lampe, K., Gutierrez, F. R. S., Boon, L., Herbert, D. R., & Aliberti, J. (2013) · European Journal of Immunology · doi:10.1002/eji.201343658 · Cited by 24
Role of group 3 innate lymphoid cells in antibody production
Magri, G., & Cerutti, A. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.01.008 · Cited by 24
Ito, K., Nakajima, A., Fukushima, Y., Suzuki, K., Sakamoto, K., Hamazaki, Y., Ogasawara, K., Minato, N., & Hattori, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173629 · Cited by 24
Self-citationThe risks of targeting co-inhibitory pathways to modulate pathogen-directed T cell responses
Frebel, H., & Oxenius, A. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.12.002 · Cited by 23
“34, No. 5”
Mucosal Mesenchymal Cells: Secondary Barrier and Peripheral Educator for the Gut Immune System
Kurashima, Y., Yamamoto, D., Nelson, S. A., Uematsu, S., Ernst, P. B., Nakayama, T., & Kiyono, H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01787 · Cited by 23
“The qualitative and quantitative adjustment of intestinal IgA antibody production is deeply involved in both the protection against pathogenic bacterial infection and the maintenance of the appropriate composition of commensal bacterial flora for a healthy gut environment (55).”
BackgroundSagrero‐Fabela, N., Chávez-Mireles, R., Salazar‐Camarena, D. C., & Palafox‐Sánchez, C. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147726 · Cited by 22
“Consequently, Tfh cells from Pdcd1 − / − mice produced less IL-21 than cells from wild-type (WT) mice [155].”
BackgroundPD-1 regulates ILC3-driven intestinal immunity and homeostasis
Jacquelot, N., Xiong, L., Cao, W. H. J., Huang, Q., Yu, H., Sayad, A., Anttila, C. J. A., Baldwin, T. M., Hickey, P. F., Amann‐Zalcenstein, D., et al. (2024) · Mucosal Immunology · doi:10.1016/j.mucimm.2024.03.002 · Cited by 22
PD-1 Deficiency Enhances Humoral Immunity of Malaria Infection Treatment Vaccine
Liu, T., Lu, X., Zhao, C., Fu, X., Zhao, T., & Xu, W. (2015) · Infection and Immunity · doi:10.1128/iai.02621-14 · Cited by 22
Predictive Biomarkers for PD-1 and PD-L1 Immune Checkpoint Blockade Therapy
Song, Y., Li, Z., Xue, W., & Zhang, M. (2019) · Immunotherapy · doi:10.2217/imt-2018-0173 · Cited by 22
Urinary Metabolic Markers of Bladder Cancer: A Reflection of the Tumor or the Response of the Body?
Petrella, G., Ciufolini, G., Vago, R., & Cicero, D. O. (2021) · Metabolites · doi:10.3390/metabo11110756 · Cited by 22
Stienne, C., Virgen‐Slane, R., Elmeń, L., Veny, M., Huang, S. X. L., Nguyen, J., Chappell, E., Balmert, M. O., Shui, J., Hurchla, M. A., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110553 · Cited by 22
“Pdcd1-deficient animals showed impaired control of IgA, microbial dysbiosis, and strain-dependent autoimmune disease susceptibility, similar to Btla-deficient strains (Kawamoto et al., 2012; Zhang and Vignali, 2016).”
Pedros, C., Altman, A., & Kong, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02412 · Cited by 22
“Surprisingly, the absence of PD-1 signals leads to a reduction of B cell responses in some studies, despite an expansion of the TFH cell population (129, 131, 133).”
BackgroundMucosal immunology and bacterial handling in the intestine
Rescigno, M. (2013) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2013.03.004 · Cited by 21
“In the absence of PD-1 the selection of IgA precursor cells in the Peyer’s Patches is aberrant and this results in the alteration of microbial communities in the gut [55].”
BackgroundWu, X., Su, Z., Cai, B., Yan, L., Li, Y., Feng, W., & Wang, L. (2018) · Viral Immunology · doi:10.1089/vim.2017.0171 · Cited by 21
“Shinmei’s study demonstrated that excess TFH was found in PD-1 deficiency mice (15).”
Immunity orchestrates a bridge in gut-brain axis of neurodegenerative diseases
Cheng, Y., Chen, C., & Zhang, F. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101857 · Cited by 21
Cell Based Assays: the Cell Cycle, Cell Proliferation and Cell Death
Cobb, L. J. (2013) · Materials and Methods · doi:10.13070/mm.en.3.172 · Cited by 21
Bruyne, R. D., Gevaert, P., Winckel, M. V., Ruyck, N. D., Minne, A., Bogaert, D., Biervliet, S. V., Velde, S. V., Smets, F., Sokal, E. M., et al. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12514 · Cited by 21
PD-1 deficiency protects experimental colitis via alteration of gut microbiota
Park, S. J., Kim, J., Song, M.-Y., Sung, Y. C., Lee, S., & Park, Y. (2017) · BMB Reports · doi:10.5483/bmbrep.2017.50.11.165 · Cited by 21
“Composition of gut microbiota is altered in PD-1-deficient mice Since our data in cohousing experiment supports the previous report showing altered composition of microbiota in PD-1−/− mice (23), we next characterize microbial communities through 16S rRNA gene-pyrosequencing analysis with cecal contents of WT or PD-1−…”
BackgroundResultZhang, L., Li, H., Ren, H., & Hu, P. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.10.011 · Cited by 20
Li, L., Ma, Y., Xu, Y., & Maerkeya, K. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.02.016 · Cited by 20
Seidl, M., Bader, M., Vaihinger, A., Wellner, U. F., Todorova, R., Herde, B., Schrenk, K., Maurer, J., Schilling, O., Erbes, T., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23629-3 · Cited by 20
Gut microbiota composition is associated with the efficacy of Delta-24-RGDOX in malignant gliomas
Meléndez-Vázquez, N. M., Nguyen, T. T., Fan, X., Lopez-Rivas, A. R., Fueyo-Margareto, J., Gomez‐Manzano, C., & Godoy‐Vitorino, F. (2024) · Molecular Therapy Oncology · doi:10.1016/j.omton.2024.200787 · Cited by 19
“51 In a previous study by our team, CD4 + T cell depletion in a GBM mouse cohort resulted in lower mouse survival and lower ef fi cacy of the oncolytic virus therapy, 24 here correlated with gut dysbiosis.”
BackgroundB cell senescence promotes age‐related changes in oral microbiota
Mizuno, H., Kawamoto, S., Uemura, K., Park, J. H., Hori, N., Okumura, Y., Konishi, Y., & Hara, E. (2024) · Aging Cell · doi:10.1111/acel.14304 · Cited by 19
“…in both human and murine models (Catanzaro et al., 2019 ; Fadlallah et al., 2018; Fagarasan et al., 2002; Moll et al., 2021 ; Suzuki et al., 2004 ), with implications for the development of autoimmune disorders through aberrant immune activation (Kawamoto et al., 2012 ; Nagaishi et al., 2022 ).”
Self-citationLeigh, S., Lynch, C. M. K., Bird, B., Griffin, B. T., Cryan, J. F., & Clarke, G. A. (2022) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2022.2043849 · Cited by 19
“Moreover, programmed cell death protein 1 (PD-1), a key target of ICIs, is known to play a role in host immune regulation of the gut microbiota [56].”
BackgroundDiversified IgA–Bacteria Interaction in Gut Homeostasis
Suzuki, K. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-3532-1_9 · Cited by 17
Self-citationCritical Role of Intestinal Microbiota in ATF3-Mediated Gut Immune Homeostasis
Cao, Y., Wang, X., Yang, Q., Deng, H., Liu, Y., Zhou, P., Xu, H., Chen, D., Feng, D.-Y., Zhang, H., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901000 · Cited by 18
“Recently, several molecules were reported to mediate the interaction between IgA and microbiota in gut, including the inhibitory coreceptor PD-1 (38), innate adaptor MyD88 (28), and the ATP-gated ionotropic P2 3 7 receptor (39).”
BackgroundInfluentialT cell help in the autoreactive germinal center
Akama‐Garren, E. H., & Carroll, M. C. (2022) · Scandinavian Journal of Immunology · doi:10.1111/sji.13192 · Cited by 17
Zhao, F., Zhu, J., Yu, R., Shao, T., Chen, S., Zhang, G., & Shu, Q. (2022) · Scientific Reports · doi:10.1038/s41598-022-24286-3 · Cited by 17
Metadata
- Authors
- Kawamoto, S., Tran, T. H., Maruya, M., Suzuki, K., Doi, Y., Tsutsui, Y., Kato, L. M., & Fagarasan, S.
- Affiliations
- RIKEN (JP)
- Hanoi Medical University (VN)
- Kyoto University (JP)
- Corresponding author
- Kawamoto, Shimpei
- Tran, Thinh H.
- Maruya, Mikako
- Fagarasan, Sidonia
- Venue
- Science
- Published
- 2012-04-27
- Volume
- 336
- Issue
- 6080
- Pages
- 485-489
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2012694594
- Cited by
- 451
- References
- 33
- Citations by year
- 2026: 16 · 2025: 12 · 2024: 33 · 2023: 17 · 2022: 30 · 2021: 46 · 2020: 45 · 2019: 34 · 2018: 37 · 2017: 27 · 2016: 30 · 2015: 40 · 2014: 38 · 2013: 33 · 2012: 13
- FWCI
- 17.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- PD-1, immunoglobulin A, Peyer's patches, T follicular helper cells, B cell differentiation, gut microbiota, intestinal mucosa, plasma cells
- MeSH terms
- Animals, B-Lymphocytes, Bacteria, Feces, T-Lymphocytes, Helper-Inducer, Immunoglobulin A, Intestinal Mucosa, Intestine, Small, Peyer's Patches, Plasma Cells, Symbiosis, Bacterial Physiological Phenomena, Lymphocyte Count, Germinal Center, Adoptive Transfer, Genes, Immunoglobulin Heavy Chain, Mice, Bacterial Load, Programmed Cell Death 1 Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.